Onconetix Free Cash Flow (FCF) History (ONCO)

Onconetix reported −$10.5M in free cash flow for fiscal 2024, an increase of $3.1M from the previous fiscal year, with a free cash flow margin of −416.95%.

View full Onconetix company overview

Onconetix free cash flow by year

Onconetix annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20242024-12-31−$10.5M$3.1M—−416.95%
20232023-12-31−$13.6M−$4.9M—−23234.96%
20222022-12-31−$8.7M−$6.6M——
20212021-12-31−$2.0M———

Onconetix free cash flow growth trends

Onconetix's latest reported quarter, Q4 2024, generated −$921,521 in free cash flow, an increase of $3.4M year over year.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review Onconetix source filings ↗

Community posts

It’s quiet here.

No posts about ONCO yet. Start the conversation.

Write the first post